Skip to main content

  • Register
  • Sign in
  • HOME
  • ABOUT
    • Meet the EpiCreators
    • Why focus on the epithelium?
  • EPIFUNDAMENTALS
    • UNMET NEED
    • Unmet needs in severe asthma
    • Complexity of severe asthma
    • UPPER AIRWAY
    • United airway disease
    • The role of the epithelium in rhinitis
    • Chronic rhinosinusitis and the central role of the nasal epithelium
    • LOWER AIRWAY
    • Role of the epithelium in asthma
    • Epithelial cytokines and the inflammatory cascade
    • Airway hyperresponsiveness in severe asthma
    • Airway remodelling in severe asthma
    • The role of the epithelium and epithelial cytokines in COPD
    • REMISSION
    • Achieving remission in airway diseases
  • CONGRESS HIGHLIGHTS
  • Scientific & Resource Library

EPICENTRAL

By clicking on this link, you will be leaving the website. Please ensure that you read the legal and privacy policy sections of any website to which you link.

Cancel Proceed

Fullscreen Content

The following content is best viewed on a desktop and has not been optimised for use on mobile and tablet devices. The content will appear fullscreen.

Exit Proceed

EPICENTRAL

This content is no longer available.

Please explore the EpiCentral website for more educational material and resources.

Close
Back

EpiCentral Feedback Survey

The EpiCentral platform is regularly updated with new content to enhance the user experience.
We would be grateful if you could complete our short survey on your experience.

The survey takes less than 5 minutes and your responses are anonymous.

EpiCentral logo

  • LEGAL NOTICE
  • PRIVACY POLICY
  • COOKIE POLICY
  • CONTACT US
Veeva ID: GB-61844; date of preparation: January 2025.
© 2026 AstraZeneca. All rights reserved. This information is intended for UK healthcare professionals only. EpiCentral is sponsored and developed by AstraZeneca.
Amgen logo
Astra Zeneca logo
Veeva ID: GB-61844; date of preparation: January 2025.
© 2026 AstraZeneca. All rights reserved. This information is intended for UK healthcare professionals only. EpiCentral is sponsored and developed by AstraZeneca.